Inmed Pharmaceuticals Inc Stock (INM) Forecast
The Inmed Pharmaceuticals Inc (INM) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $76.40, representing a +478.36% increase from the current price of $13.21. The highest analyst price target is $147.60, and the lowest is $5.20.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month INM Price Target
Average 108.74 (+723.18% Upside)
Is Inmed Pharmaceuticals Inc (INM) A Buy Now?
Oscillators
Buy: 3 · Sell: 4 · Neutral: 0Summary: Sell
Moving Averages
Buy: 10 · Sell: 0 · Neutral: 0Summary: Buy
According to our latest analysis, INM could be considered a Strong Buy, with 17 technical analysis indicators signaling 13 Buy signals, 4 signaling Sell signals and 0 Neutral signals. This might be a good time to open fresh positions on INM, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 99.60 indicates that INM is overbought. This suggests that INM price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 84.74 indicates that INM is overbought. This means that INM price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100.00 indicates that INM is overbought. This suggests that INM price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of 48.33 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of 551.63 indicates that INM is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term INM price forecast for 2026, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Inmed Pharmaceuticals Inc financial reports and earnings history, Inmed Pharmaceuticals Inc (INM) stock could reach $149.74 by 2030, $681.58 by 2040 and $1,350.72 by 2050. See the projected annual prices until 2050 of the Inmed Pharmaceuticals Inc stock below:
- Inmed Pharmaceuticals Inc (INM) is expected to reach an average price of $270.95 in 2035, with a high prediction of $384.08 and a low estimate of $271.60. This indicates an +1,951% change from the last recorded price of $13.21.
- Inmed Pharmaceuticals Inc (INM) stock is projected to chart a bullish course in 2040, with an average price target of $520.18, representing an +3,838% change from its current level. The forecast ranges from a conservative $520.19 to a sky-high $681.58.
- Our analysts predict Inmed Pharmaceuticals Inc (INM) to change +6,285% by 2045, soaring from $844.30 to an average price of $843.48, potentially reaching $1,044.51. While $844.30 is the low estimate, the potential upside is significant.
- Inmed Pharmaceuticals Inc (INM) stock is expected to climb by 2050, reaching an average of $1,238.81, a +9,278% change from its current level. However, a wide range of estimates exists, with high and low targets of $1,350.72 and $1,240.80, respectively, highlighting the market's uncertainty.
Inmed Pharmaceuticals Inc Stock (INM) Year by Year Forecast
Inmed Pharmaceuticals Inc Stock (INM) Price Forecast for 2026
The predicted value for Inmed Pharmaceuticals Inc (INM) in 2026 is set at an average of $16.13. Estimates vary from a peak of $256.81 to a trough of $0.2875, indicating an +22.07% surge from the present price of $13.21.
Inmed Pharmaceuticals Inc Stock (INM) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Inmed Pharmaceuticals Inc (INM) is $135.98, with a high forecast of $239.67 and a low forecast of $3.00. This indicates an +929.40% increase from the last price of $13.21.
Inmed Pharmaceuticals Inc Stock (INM) Price Forecast for 2028
In 2028, Inmed Pharmaceuticals Inc (INM) is projected to reach an average price of $226.83, with a high projection of $245.19 and a low estimate of $207.29. This indicates an +1,617% rise from the last price of $13.21.
Inmed Pharmaceuticals Inc Stock (INM) Price Forecast for 2029
The 2029 price forecast for Inmed Pharmaceuticals Inc Stock (INM) is $180.01 on average, with a high prediction of $205.87 and a low estimate of $155.27. This represents an +1,263% increase from the previous price of $13.21.
Inmed Pharmaceuticals Inc Stock (INM) Price Forecast for 2030
Inmed Pharmaceuticals Inc Stock (INM) is expected to reach an average price of $124.34 in 2030, with a high forecast of $149.74 and a low forecast of $98.05. This signifies an +841.28% surge from the last price of $13.21.
